Search results
Author(s):
Heather Currie
,
Christine Williams
Added:
3 years ago
Cardiovascular disease (CVD) is the leading cause of death in both men and women, yet the extent of the problem in women is frequently underestimated and, compared with men, women are less likely to be offered interventions, are less likely to be represented in clinical trials and have a worse prognosis. This article aims to examine the extent of the problem of CVD in women, summarise the…
View more
Author(s):
Nieca Goldberg
Added:
3 years ago
Cardiovascular disease (CVD) is the leading cause of death and disability in American women. Since 1984, more women have died of cardiovascular disease than men. More than 200,000 of these deaths are due to coronary heart disease.1 In two-thirds of these women, sudden death was the presenting symptom and studies2 show that 90% of them had at least one of the modifiable risk factors (e.g…
View more
Author(s):
Abdulah Alrifai
,
Mohamad Kabach
,
Jonathan Nieves
,
et al
Added:
3 years ago
More than 10 million Americans suffer annually from angina.1 For decades, most of the attention has been focused on epicardial coronary artery disease (CAD). In a European registry of 11,000 stable angina patients, 65% of women and 32% of men had no obstructive CAD (<50% stenosis); however, multiple other studies have demonstrated only 30% of patients have significant obstructive epicardial…
View more
Author(s):
Aniket S Rali
,
Andrew J Sauer
Added:
3 years ago
In late December 2019, an outbreak of an unknown disease called a pneumonia of uncertain cause occurred in Wuhan, Hubei Province, China.1 Over the next few days, several independent laboratories identified the causative agent as a novel coronavirus.2–4 The WHO has temporarily named this virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the related infectious disease…
View more
Author(s):
Michael F Morris
,
Philip A Araoz
Added:
3 years ago
Mitral valve dysfunction is the most common cause of valvular disease in the US.1 Although echocardiography is the primary non-invasive modality for visualizing the mitral valve, advances in technology continue to allow for improved evaluation of mitral disease with magnetic resonance imaging (MRI) and computed tomography (CT).2,3 Currently, the role for MRI and CT assessment of the mitral valve…
View more
Author(s):
Venu Menon
Added:
3 years ago
The management of patients with stable coronary artery disease (CAD) is characterised by the utilisation of proven medical therapy and on-going effective risk stratification. Periodic assessment of patient symptomatology and functionality; evaluation and control of traditional risk factors; presence and extent of ischaemia; extent of CAD and left ventricular (LV) function; and referral to…
View more
Author(s):
Venu Menon
Added:
3 years ago
The management of patients with stable coronary artery disease (CAD) is characterised by the utilisation of proven medical therapy and on-going effective risk stratification. Periodic assessment of patient symptomatology and functionality; evaluation and control of traditional risk factors; presence and extent of ischaemia; extent of CAD and left ventricular (LV) function; and referral to…
View more
Author(s):
David Playford
Added:
3 years ago
Prof David Playford (University of Notre Dame, Fremantle, WA, AU) discusses the lessons from the National Echocardiography Database of Australia (NEDA) in relation to preserved ejection fraction and structural heart disease in 446,848 patients.
Recorded remotely from Fremantle, 2020.
Questions:
1. What is the rationale of this study?
2. What were the aims of this study?
3. What were the…
View more
Author(s):
Karthiek R Narala
,
Thomas A LaLonde
,
Sohail Hassan
,
et al
Added:
3 years ago
Chronic kidney disease (CKD) affects approximately 26 million people in the US.1 CKD is considered a coronary risk equivalent and also a risk factor for progression of cardiovascular disease (CVD).2 Cardiovascular death rates are 10–30 times higher in dialysis patients than in the general population.3 This increase in CKD patients is multifactorial and is now mainly considered via two pathways:…
View more
Author(s):
Jennifer S Li
,
YT Chen
,
Claire Morgan
,
et al
Added:
3 years ago
Overview
Pompe disease, also known as glycogen storage disease type II or acid maltase deficiency, is a rare, debilitating, and often fatal lysosomal storage disease. It is caused by an autosomal recessively inherited deficiency of the enzyme acid α-glucosidase (GAA) that hydrolyzes glycogen to glucose in the lysosome; the deficiency causes the deposition of glycogen in multiple tissues,…
View more